Survival

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study
Dietary inflammatory index and prostate cancer survival
Embryonal cancers in Europe
Epidemiology of glial and non-glial brain tumours in Europe
Epidemiology of rare cancers and inequalities in oncologic outcomes
Fruit and vegetables consumption is directly associated to survival after prostate cancer
Geographical variability in survival of European children with central nervous system tumours
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
I pazienti lungo sopravviventi per neoplasie in età pediatrica
Incidence and survival of rare urogenital cancers in Europe
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002
Indicators of long-term survival and cure of cancer
Indicators of long-term survival and cure of cancer
Indicators of long-term survival and cure of cancer
Indicators of long-term survival and cure of cancer
Italian cancer figures - Report 2015: The burden of rare cancers in Italy
Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project

Pagina 1 di 3

Inizio
Indietro
1
2
3
Avanti
Fine

Questo sito web utilizza cookies per fornirti una migliore esperienza di navigazione. Scopri di più.